Peter Knox

Plutus Resources Plc focuses on investments in the natural resource sector. It seeks to acquire a direct and/or an indirect interest in projects and assets in the oil and gas sector primarily in Europe, North America, and Africa. The company was founded by Simon Dennis Hunt, Simon Nicholas Haworth and Philip Nicholas Rodgers on April 4, 2005 and is headquartered in London, the United Kingdom.

Metris Therapeutics Ltd. develops pharmaceutical products. It is engaged in the research and development of medicines for the treatment of women's health disorders. The firm develops medicines to treat endometriosis, menstrual pain, and menopause symptoms. The company was founded by Stephen Smith in 1996 and is headquartered in Wokingham, UK.

Systemantics India Pvt Ltd. designs, manufactures, and markets factory automation components and systems. Its development approach replaces steel with silicon, offers graded functionality options to match end-user requirement, partners with domestic companies for component development and production for scale, quality, and cost, and, localizes key components for better access, customization, spares, and service. The company was founded by Jagannath Raju on May 1, 1995 and is headquartered in Bangalore, India.

TAP Biosystems Ltd. designs and develops automated cell culture and fermentation systems for life science research. The private company is based in Royston, UK.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Medermica Ltd. develops diagnostic and sensor technologies for laboratory and healthcare applications. The company's technologies included pH sensor, wound infection diagnostic and buffering capacity. It also identified technology opportunities, validates the science, assesses the commercial opportunity, creates early prototype devices, and conducts proof-of-concept studies. Medermica was founded in 2005 and was headquartered in London, GB.